Pharmacokinetics (PK) and efficacy of S-1 plus cisplatin (CDDP) in patients with advanced gastric cancer (GC): A phase I/II study.

被引：0
|
作者：
Koizumi, W
Tanabe, S
Saigenji, K
Ohtsu, A
Boku, N
Nagashima, F
Muto, M
机构：
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
537
引用
收藏
页码：4573S / 4574S
页数：2
相关论文
共 50 条
  • [1] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [2] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
    Hosokawa, A.
    Ogawa, K.
    Kajiura, S.
    Tsukioka, Y.
    Kobayashi, T.
    Horikawa, N.
    Kobayashi, Y.
    Yoshioka, A.
    Sumi, S.
    Sugiyama, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [3] Multicenter phase II study of triple combination with S-1 and cisplatin (CDDP) plus paclitaxel (TXL) in patients with advanced gastric cancer
    Iwase, H.
    Tsuzuki, T.
    Shimada, M.
    Ina, K.
    Shinoda, M.
    Kumada, J.
    Okamura, S.
    Haruta, J.
    Sugihara, M.
    Goto, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Randomized phase II study of S-1/CDDP plus TSU-68 versus S-1/CDDP in patients with advanced gastric cancer
    Yamaguchi, Kensei
    Koizumi, Wasaburo
    Hosaka, Hisashi
    Takinishi, Yasutaka
    Nakayama, Norisuke
    Hara, Takuo
    Muro, Kei
    Baba, Hideo
    Sasaki, Yasutsuna
    Nishina, Tomohiro
    Fuse, Nozomu
    Esaki, Taito
    Takagi, Masakazu
    Gotoh, Masahiro
    Kitamura, Ryuichi
    Matsumoto, Hideki
    Sasaki, Tsuneo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    W Koizumi
    S Tanabe
    K Saigenji
    A Ohtsu
    N Boku
    F Nagashima
    K Shirao
    Y Matsumura
    M Gotoh
    [J]. British Journal of Cancer, 2003, 89 : 2207 - 2212
  • [6] Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    Koizumi, W
    Tanabe, S
    Saigenji, K
    Ohtsu, A
    Boku, N
    Nagashima, F
    Shirao, K
    Matsumura, Y
    Gotoh, M
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (12) : 2207 - 2212
  • [7] A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer
    Yasuhide Yamada
    Naomi Kiyota
    Nozomu Fuse
    Ken Kato
    Hironobu Minami
    Kensei Hashizume
    Yoshihiro Kuroki
    Yuichiro Ito
    Atsushi Ohtsu
    [J]. Gastric Cancer, 2014, 17 : 161 - 172
  • [8] A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer
    Yamada, Yasuhide
    Kiyota, Naomi
    Fuse, Nozomu
    Kato, Ken
    Minami, Hironobu
    Hashizume, Kensei
    Kuroki, Yoshihiro
    Ito, Yuichiro
    Ohtsu, Atsushi
    [J]. GASTRIC CANCER, 2014, 17 (01) : 161 - 172
  • [9] PHASE I STUDY OF SUNITINIB (SU) PLUS S-1 AND CISPLATIN (P) IN PATIENTS (PTS) WITH ADVANCED OR METASTATIC GASTRIC CANCER (GC)
    Muro, K.
    Miyata, Y.
    Li, M.
    Watanabe, K.
    Boku, N.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 255 - 255
  • [10] A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen
    Sato Y.
    Kondo H.
    Honda K.
    Takahari D.
    Sumiyoshi T.
    Tsuji Y.
    Yoshizaki N.
    Niitsu Y.
    [J]. International Journal of Clinical Oncology, 2005, 10 (1) : 40 - 44
12345